Literature DB >> 33402083

Applications of ROS-Induced Zr-MOFs Platform in Multimodal Synergistic Therapy.

Qiongjie Ding1, Yiwei Liu1, Chuncheng Shi2, Jifei Xiao3, Wei Dai1, Dong Liu4, Haoyuan Chen1, Baohong Li1, Jianqiang Liu1.   

Abstract

BACKGROUND: Metal-organic frameworks (MOFs) exhibited the adjustable aperture, high load capacities, tailorable structures, and excellent biocompatibilities that have used to be as drug delivery carries in cancer therapy. Until now, Zr-MOFs in particular combine optimal stability towards hydrolysis and postsynthetic modification with low toxicity, and are widely studied for its excellent biological performance.
INTRODUCTION: This review comprises the exploration of Zr-MOFs as drug delivery devices (DDSs) with focus on various new methods, including chemotherapy (CT), photodynamic therapy (PDT), photothermal therapy (PTT), sonodynamic therapy(SDT), radiotherapy, immunotherapy, gene therapy and related combined therapies, which all generate reactive oxygen species (ROS) to achieve the high efficiency of tumor therapy.
CONCLUSION: We described and summarized these pertinent examples of the therapeutic mechanisms and highlight the antitumor effects of their biological application both in vitro and in vivo. The perspectives on their future applications and analogous challenge of the Zr-MOFs materials are given. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  ROS; Zr-MOFs; drug delivery; photodynamic therapy; synergistic therapy.

Year:  2021        PMID: 33402083     DOI: 10.2174/1389557521666210105111850

Source DB:  PubMed          Journal:  Mini Rev Med Chem        ISSN: 1389-5575            Impact factor:   3.862


  1 in total

1.  Structures of Dimer-of-Dimers Type Defect Cubane Tetranuclear Copper(II) Complexes with Novel Dinucleating Ligands.

Authors:  Ryusei Hoshikawa; Ryoji Mitsuhashi; Eiji Asato; Jianqiang Liu; Hiroshi Sakiyama
Journal:  Molecules       Date:  2022-01-17       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.